Lv1
52 积分 2022-02-17 加入
Integrin αvβ6: Structure, function and role in health and disease
2天前
已完结
[Guidelines on the clinical management of neonatal hyperbilirubinemia (2025)]
12天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
Structural attributes influencing unbound tissue distribution
1个月前
已完结
The importance of plasma protein and tissue binding in a drug discovery program to successfully deliver a preclinical candidate
1个月前
已完结
β6‐integrin serves as a novel serum tumor marker for colorectal carcinoma
1个月前
已完结
Selection of Payloads for Antibody–Drug Conjugates Targeting Ubiquitously Expressed Tumor-Associated Antigens: a Case Study
1个月前
已完结
Mechanism-based pharmacokinetic and pharmacodynamic modeling for bispecific antibodies: challenges and opportunities
3个月前
已完结
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
3个月前
已完结
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
3个月前
已完结
皖公网安备34019202002308
